Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.67 |
| ▸ | LMNA | P02545 | 4/20 | 0.67 |
| ▸ | MAPT | P10636 | 4/20 | 0.67 |
| ▸ | SERPINA6 | P08185 | 4/20 | 0.67 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.67 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.67 |
| ▸ | TSHR | P16473 | 2/20 | 0.67 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.67 |
| ▸ | MEN1 | O00255 | 2/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.67 |
| ▸ | ABCB11 | O95342 | 2/20 | 0.67 |
| ▸ | SHBG | P04278 | 2/20 | 0.67 |
| ▸ | NR3C2 | P08235 | 2/20 | 0.67 |
| ▸ | GPBAR1 | Q8TDU6 | 2/20 | 0.67 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.67 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.67 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL582377 | 0.98 | ALDH1A1 (0.64) | ALDH1A1CYP3A4SMN1; SMN2LMNAMAPT | |
| SCHEMBL220822 | 0.91 | ALDH1A1 (0.62) | ALDH1A1CYP3A4SMN1; SMN2LMNAMAPT | |
| SCHEMBL9360183 | 0.91 | CYP3A4 (0.62) | ALDH1A1CYP3A4SMN1; SMN2LMNAMAPT | |
| SCHEMBL10893814 | 0.91 | ALDH1A1 (0.62) | ALDH1A1CYP3A4SMN1; SMN2LMNAMAPT | |
| SCHEMBL6684640 | 0.90 | CYP3A4 (0.61) | ALDH1A1CYP3A4SMN1; SMN2LMNAMAPT | |
| SCHEMBL28255051 | 0.88 | CYP3A4 (0.59) | ALDH1A1CYP3A4SMN1; SMN2LMNAMAPT | |
| Water SCHEMBL15951778 | 0.88 | ALDH1A1 (0.59) | ALDH1A1CYP3A4SMN1; SMN2LMNAMAPT | |
| SCHEMBL4749451 | 0.88 | ALDH1A1 (0.59) | ALDH1A1CYP3A4SMN1; SMN2LMNAMAPT | |
| SCHEMBL28718285 | 0.88 | CYP3A4 (0.59) | ALDH1A1CYP3A4SMN1; SMN2LMNAMAPT | |
| SCHEMBL2042111 | 0.87 | CYP3A4 (0.58) | ALDH1A1CYP3A4SMN1; SMN2LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 131 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109966502-B | Composition for improving solubility of poorly soluble substance, use thereof, and complex preparation containing same | 财团法人工业技术研究院 | 2023-01-24 | — | — | CN | claimed |
| US-20190209706-A1 | COMPOSITION FOR IMPROVING THE SOLUBILITY OF POORLY SOLUBLE SUBSTANCES, USE THEREOF AND COMPLEX FORMULATION CONTAINING THEREOF | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2019-07-11 | — | — | US | claimed |
| CN-109966502-A | For improve the composition of the solubility of indissoluble object, its purposes with containing its compound formulation | 财团法人工业技术研究院 | 2019-07-05 | — | — | CN | claimed |
| EP-1922094-B1 | DEVICES FOR LYMPHATIC TARGETING | LIU JIANG (CN) | 2015-09-30 | — | — | EP | claimed |
| EP-2773333-A1 | DERMAL DELIVERY COMPOSITIONS AND METHODS | Agile Therapeutics, Inc. (US) | 2014-09-10 | — | — | EP | claimed |
| WO-2013067346-A1 | DERMAL DELIVERY COMPOSITIONS AND METHODS | AGILE THERAPEUTICS, INC. (US) | 2013-05-10 | — | — | WO | claimed |
| EP-0579435-B1 | Cyclodextrin complexation | CYCLOPS H F (IS) | 1999-03-17 | — | — | EP | claimed |
| US-4215691-A | Vaginal contraceptive system made from block copolymer | ALZA CORPORATION (US) | 1980-08-05 | — | — | US | claimed |
| JP-9315977-A | — | — | None | — | — | JP | disclosed |
| US-20240016954-A1 | COMPOSITION FOR IMPROVING THE SOLUBILITY OF POORLY SOLUBLE SUBSTANCES, COMPLEX FORMULATION AND LIQUID FORMULATION OF AN ACTIVE INGREDIENT | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2024-01-18 | — | — | US | disclosed |
| US-11801310-B2 | Composition for improving the solubility of poorly soluble substances, use thereof and complex formulation containing thereof | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2023-10-31 | — | — | US | disclosed |
| CN-115850248-A | Teninil antitumor drug compound and preparation method and application thereof | 南京友怡医药科技有限公司 | 2023-03-28 | — | — | CN | disclosed |
| CN-115768464-A | Methods of generating engineered memory-like NK cells and compositions thereof | 麻省理工学院 | 2023-03-07 | — | — | CN | disclosed |
| CN-109966502-B | Composition for improving solubility of poorly soluble substance, use thereof, and complex preparation containing same | 财团法人工业技术研究院 | 2023-01-24 | — | — | CN | disclosed |
| WO-1993002065-A1 | NEW DERIVATIVES OF TAXOL ANALOGUES, PREPARATION THEREOF AND COMPOSITIONS CONTAINING THEM | RHONE-POULENC RORER S.A. (FR) | 1993-02-04 | — | — | WO | disclosed |
| EP-0524093-A1 | Derivatives of analogues of taxol, their preparation and compositons containing them | Aventis Pharma S.A. (FR) | 1993-01-20 | — | — | EP | disclosed |
| EP-0514373-A1 | Use of melatonin for treating pre-menstrual syndrome. | AMR INT (US) | 1992-11-25 | — | — | EP | disclosed |
| WO-1992009589-A1 | METHOD FOR PREPARING TAXANE DERIVATIVES, NOVEL DERIVATIVES THEREBY OBTAINED AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | RHONE-POULENC RORER S.A. (FR) | 1992-06-11 | — | — | WO | disclosed |
| WO-1991012007-A1 | METHOD OF TREATING PRE-MENSTRUAL SYNDROME | APPLIED MED RES (US) | 1991-08-22 | — | — | WO | disclosed |
| US-4945103-A | Method of treating pre-menstrual syndrome | APPLIED MEDICAL RESEARCH | 1990-07-31 | — | — | US | disclosed |